Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 45.95 is 67% below its 2-year average of 139.05, near the low end of its 2-year range (0.00–1110.65).
As of the fiscal period ended Tuesday, June 30, 2026. 17.25% below its 12-month average of 55.53.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 45.95.
CURRENT RATIO
45.95
CURRENT RATIO AVG TTM
55.53
CURRENT RATIO AVG 3Y
N/A
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-17.25%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+1125.37%
vs the sector median at left
Curanex Pharmaceuticals Inc Common Stock
Market Cap
$7.01M
Current Ratio
45.95
TTM Avg
55.53
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.95M
Current Ratio
0.31
TTM Avg
1.26
3Y Avg
1.91
5Y Avg
5.47
Market Cap
$6.78M
Current Ratio
2.61
TTM Avg
3.40
3Y Avg
4.86
5Y Avg
5.09
Market Cap
$7.32M
Current Ratio
1.37
TTM Avg
4.18
3Y Avg
4.61
5Y Avg
4.18
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Curanex Pharmaceuticals Inc Common Stock (CURX) | $7.01M | 45.95 | 55.53 | N/A | N/A |
| KALA BIO, Inc. (KALA)vs › | $7.02M | 6.88 | 3.46 | 4.15 | 4.60 |
| Co-Diagnostics, Inc. (CODX)vs › | $6.97M | 1.81 | 4.14 | 10.76 | 11.50 |
| Exicure, Inc. (XCUR)vs › | $6.82M | 0.56 | 2.82 | 3.15 | 3.36 |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $6.95M | 0.31 | 1.26 | 1.91 | 5.47 |
| Mangoceuticals, Inc. (MGRX)vs › | $7.07M | 0.18 | 0.90 | 2.08 | 1.78 |
| Longeveron Inc. (LGVN)vs › | $7.21M | 2.63 | 4.46 | 3.65 | 4.69 |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.78M | 2.61 | 3.40 | 4.86 | 5.09 |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.32M | 1.37 | 4.18 | 4.61 | 4.18 |
| Skye Bioscience, Inc. (SKYE)vs › | $7.53M | 0.95 | 9.81 | 5.30 | 4.51 |
Current Ratio
45.95
Quick Ratio
45.95
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 45.95 |
| 2026-03-31 | 62.87 |
| 2025-12-31 | 81.93 |
| 2025-09-30 | 77.53 |
| 2025-06-30 | 9.37 |
| 2025-03-31 | 3.61 |
| 2024-12-31 | 35.54 |
| 2024-09-30 | 102.04 |
| 2024-06-30 | 1110.65 |
| 2024-03-31 | 0.00 |
| 2023-12-31 | 0.00 |
